(Q45585200)

14 December 2017

title

Atorvastatin treatment affects atrial ion currents and their tachycardia-induced remodeling in rabbits (English)

1 reference

14 December 2017

Roman Laszlo

1

1 reference

14 December 2017

Karen Anna Menzel

2

1 reference

14 December 2017

Kerstin Bentz

3

1 reference

14 December 2017

Birgit Schreiner

4

1 reference

14 December 2017

Klaus Kettering

5

1 reference

14 December 2017

Christian Eick

6

1 reference

14 December 2017

Juergen Schreieck

7

1 reference

14 December 2017

language of work or name

English

0 references

publication date

17 September 2010

1 reference

full work available at URL

14 December 2017

https://api.elsevier.com/content/article/PII:S0024320510003851?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

https://api.elsevier.com/content/article/PII:S0024320510003851?httpAccept=text/plain

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

15 July 2024

1 reference

14 December 2017

volume

87

1 reference

14 December 2017

issue

15-16

1 reference

14 December 2017

page(s)

507-513

1 reference

Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

14 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Electrical, contractile and structural remodeling during atrial fibrillation

15 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Statins and modulation of oxidative stress.

15 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Adverse effects of statins - mechanisms and consequences

15 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Ionic mechanisms of electrical remodeling in human atrial fibrillation

15 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces I(Ca,L) and I(to) in rapid atrial pacing in rabbits

15 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Downregulation of Endocardial Nitric Oxide Synthase Expression and Nitric Oxide Production in Atrial Fibrillation

15 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

15 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation

15 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Histological substrate of atrial biopsies in patients with lone atrial fibrillation

15 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ

15 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Pleiotropic effects of statins in atrial fibrillation patients: the evidence

15 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Evidence for the regulation of L-type Ca2+ channels in the heart by reactive oxygen species: mechanism for mediating pathology

15 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells

15 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data

15 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C.

15 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation

15 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Novel non-pharmacological approaches for antiarrhythmic therapy of atrial fibrillation

15 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

The antioxidant effects of statins may extend beyond atherosclerosis: potential benefits for atrial fibrillation and heart failure

15 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress

15 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation

15 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Do statins have an antiarrhythmic activity?

15 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atri

15 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Effect of verapamil on tachycardia-induced early cellular electrical remodeling in rabbit atrium

15 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Transient outward potassium current in rabbit atrium is depressed after short-time rapid atrial pacing but recovers after a longer pacing period

15 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Beyond lipid-lowering: effects of statins on endothelial nitric oxide

15 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

15 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Impact of HMG CoA reductase inhibition on small GTPases in the heart

15 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Treatment and prevention of atrial fibrillation with non-antiarrhythmic pharmacologic therapy

15 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells

15 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Treatment of atrial fibrillation in every days practice

15 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation

15 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits

15 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.

15 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Atrial remodeling and atrial fibrillation: mechanisms and implications.

15 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Animal models for atrial fibrillation: clinical insights and scientific opportunities.

15 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Atrial arrhythmias after cardiothoracic surgery

15 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation

15 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway

15 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

A metabolic mechanism for cardiac K+ channel remodelling

15 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Statins and polyunsaturated fatty acids for treatment of atrial fibrillation

15 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy

15 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs

15 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Upstream therapy of atrial fibrillation

15 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

15 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.

15 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization

15 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Angiotensin II increases expression of alpha1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes

15 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation

15 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Atrial L-type Ca2+ currents and human atrial fibrillation

15 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Effects of atorvastatin and simvastatin on atrial plateau currents.

15 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Potential molecular basis of different physiological properties of the transient outward K+ current in rabbit and human atrial myocytes.

15 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

15 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation

15 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

15 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Cellular bases for human atrial fibrillation

15 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation

15 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.LFS.2010.09.010

15 July 2024

Identifiers

1 reference

14 December 2017

1 reference